1. Transpharmation Ltd. Announces Strategic Acquisition of Saretius Ltd.
2. Society for Neuroscience 2024
3. Neuropsychiatric Drug Development Summit
4. Safety Pharmacology Society (SPS)
5. ILAE - 15th European Epilepsy congress
6. Kansas City Animal Health Corridor
7. IASP 2024 World Congress on Pain
8. AAIC 2024
9. OARSI 2024
10. Western Veterinary Conference
11. AD/PD 2024
12. Animal Health, Nutrition & Technology Innovation
13. VMX 2024
14. American College of Toxicology
15. Society for Neuroscience 2023
16. CNS Summit
17. Canine Conference 2023
18. ELRIG Drug Discovery
19. Animal Health, Nutrition & Technology Innovation - Asia
20. BioJapan 2023
21. 2023 SPS Annual Meeting
22. Breaking New Ground: Unleashing Canine EEG Capabilities for Enhanced Research at Transpharmation Canada.
23. The 6th Animal Health, Nutrition and Technology Innovation Meeting
24. NeuPSIG 2023
25. International League Against Epilepsy
26. The 2023 Animal Health Summit
27. Best Poster Winner!
28. Alzheimer's Association International Conference
29. Transpharmation Collaborates With Artelo Biosciences To Support Development Of Neuropathic Pain Treatment
30. 12th European Zebrafish Meeting
31. Transpharmation and Veterinary Health Research Centers Partnership
32. Published!
33. The Neuro4D Conference
34. Psychedelic Therapeutics and Drug Development Conference
35. New poster added to our publications page, recently presented at FENS
36. New poster added to our publications page, recently presented at ADPD!
37. FENS Regional Meeting 2023
38. Neuroimmunology Drug Development Summit
39. New clients, different time zones
40. AD/PD 2023
41. OARSI World Congress
42. Veterinary Meeting and Expo
43. Dr. Pabitra H. Patra paper published in PAIN
44. New published work!
45. Name change announcement, news from the CEO
46. CNS Therapeutic Xchange Europe 2022, Zurich - 24th November
47. Society for Neuroscience 2022, November 12-16, California
48. Here, there and everywhere - we love meeting up with you!
49. ECNP Congress, 15th-18th October - Vienna, Austria
50. Recent collaborative work published by Frontiers in Molecular Neuroscience
51. Global representation meeting the needs of our worldwide client base
52. Animals in scientific research, 7th Annual Conference, by PolLASA. 12-14th September, Warsaw, Poland
53. The Safety Pharmacology Society Annual Meeting - September 11-14, Montréal, Canada
54. HubXchange's US West Coast CNS Therapeutics Meeting - 29th September
55. IASP World Conference on Pain - Toronto, Canada, 19th - 23rd September
56. Rapid access to canine preclinical studies and leading PK expertise
57. Collaboration between Zebrafish Lab and Transpharmation continues
58. 5th Polish Zebrafish Society Workshop in Lublin (Poland) 29th June - 1st July
59. Progressive Ratio Task reveals effectiveness of single-dose psilocybin
60. BPS live! Rapid acting antidepressants, from ketamine to psychedelics TUESDAY 10TH, 17TH AND 24TH MAY, 2PM (BST)
61. SMi’s 22nd Annual Conference; Pain Therapeutics, 4 - 5 May, 2022, London
62. The Neuro4D Conference 2022, Mainz, Germany, 16th - 17th May 2022
63. Long term and delayed effects of psychedelics in preclinical models
64. ADPD, 16th International Conference on Alzheimer's Disease and Parkinson's Disease – 15 - 20 March 2022
65. Transpharmation’s Facilities Management Company receive AAALAC accreditation
66. Fierce Biotech report on Transpharmation and InterVivo's joint venture
67. InterVivo Solutions and Transpharmation join forces as sister companies
68. Zebrafish as a translational model for neuroscience research
69. HubXchange - CNS Therapeutics Xchange Europe 2021 – 2nd December 2021
70. The Society for Neuroscience 50th Annual Meeting will be fully virtual - 8-11 November
71. 34th ECNP Congress Hybrid - Lisbon, Portugal - 2nd - 5th October 2021
72. Neurex Neuroforum 2021
73. Cannabinoids and Psychedelics; Neuroscience Ireland Meeting 2021 - 9th-10th September 2021
74. UK scientists at Transpharmation and Clerkenwell Health combine lab and human trials, as psilocybin offers hope for people with an end-of-life diagnosis
75. FENS Regional Meeting (FRM) - 25-27 August 2021
76. InterVivo Solutions Provides Update on Cooperative Psychedelics Evaluation Platform (COPE)
77. 31st Annual International Cannabinoid Research Society (ICRS) Virtual Symposium on Cannabinoids - 21-24 June 2021
78. Transpharmation’s pain expertise recognised
79. Let us inspire you!
80. Transpharmation Ireland gains Green Labs certification
81. ICNMD – 16th International Congress on Neuromuscular Diseases Digital 2021 - 21-22 & 28-29 May 2021
82. HubXchange's US East Coast CNS Therapeutics e-Xchange Virtual meeting - 24-26 May 2021
83. SMi - 21st Annual Conference Pain Therapeutics Virtual conference - 10-11 of May 2021
84. 3rd Annual Neuroimmunology Drug Development Summit 2021 Virtual Conference – 27-29 April 2021
85. BNA 2021 - British Neuroscience Association - Festival of Neuroscience 2021 Virtual Conference 12-15 April 2021
86. “Companies have no borders”, said Mark Duxon, CEO of Transpharmation
87. ADPD, 15th International Conference on Alzheimer's Disease and Parkinson's Disease – 9-14 March 2021
88. New Laboratory
89. InterVivo Solutions Issued Institutional Cannabis Research License By Health Canada
90. ASENT - American Society of Experimental Neurotherapeutics 2021 Virtual Conference 22-25 of February 2021
91. Peer Review Journal Publication
92. Society for Neuroscience (SfN) digital event 11-13th January 2021
93. Neuronus 2020 IBRO neuroscience forum - 8th - 11th December 2020
94. Transpharmation’s expansion to world class facilities!
95. Young Investigator Symposium, 6th November 2020
96. Inflammasome Therapeutics Summit - 4th - 6th November 2020
97. Ten year anniversary!
98. Alzheimer’s Drug Discovery Foundation (ADDF) - 5th and 6th October 2020
99. WMS virtual conference - 28th September – 2nd October 2020
100. IASP